While it’s laudable to work to advance clinical trial diversity, it’s also important to widen the “aperture” to address a wide range of underserved populations, including the elderly, rural, people with disabilities, under/un-insured, and others....
Studies regarding the effect of diverse healthcare professional staff in improving outcomes for BIPOC patient populations indicate that addressing established racial and ethnic disparities in the global clinical research workforce may be an important element in promoting participant diversity....
The FDA’s recommendations to improve diversity in clinical trials provide a much-needed action plan to jumpstart the changes that need to be made to ensure inclusive care, yet these recommended guidelines only scratch the surface of ideal action in clinical trials....
Addressing the lack of mentorship for non-white professionals is an important step to providing opportunities for candidates from all backgrounds to contribute their expertise to the clinical research workforce....
Educating future and current scientists from diverse backgrounds benefits the entire biomedical research enterprise, changing the world through advances in disease diagnosis, treatment, and prevention....
Promoting a diverse clinical trial workforce is a key pillar of any effective effort to promote patient population diversity....
The clinical trial industry must be proactive and transparent in its communications with underserved communities with less access to healthcare resources and a wariness about participating in medical research....
We need a new paradigm for increasing diversity in clinical trials....
We need to widen the data net and do a better job of analyzing those data to identify clinical trials participants from previously ignored patient populations....
Although many clinical trial sponsors are broadly aware of the need for more diverse participation, most still struggle to implement specific, structural changes that will help trials better represent the wider population....
